Randomized Controlled Trial on Effectiveness of Ketorolac and Tramadol in Not Compound Fractures of Child
Overview
- Phase
- Phase 4
- Intervention
- ketorolac
- Conditions
- Fracture
- Sponsor
- IRCCS Burlo Garofolo
- Enrollment
- 133
- Locations
- 1
- Primary Endpoint
- estimation of pain reduction in every arm of the trial with linear 1-10 pain scale or for children 4 - 6 years old with analogic MacGrath type scale
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Randomized double blind Trial with the aim to estimate effectiveness of two therapeutic regimes per os on pain due to not compound bone fractures in child 4-17 years old:
- ketorolac 0,5 mg/kg (1 drop every 2 Kg)
- tramadol 2,5 mg/Kh (1 drop every 2 Kg)
Intensity of pain will be estimated with linear 1 to 10 or analogic McGrath type scale every 20 min.
The main objectives are the evaluation of pain decreasing in every group, the time of decreasing, the intensity of pain during procedures (ex. Xray) and the occurrence of side effects Secondary outcomes are comparison between the two groups on effectiveness on pain and on side effects
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children 4-17 years old with not compound bone fracture presenting in emergency room
Exclusion Criteria
- •Compound fracture
- •Occurring pain still treated
- •Contraindicated ketorolac or tramadol use
- •Informed consensus not obtained
Arms & Interventions
1
children 4-17 y. old with not compound bone fracture treated with ketorolac
Intervention: ketorolac
2
children 4-17 y. old with not compound bone fracture treated with tramadol
Intervention: tramadol
Outcomes
Primary Outcomes
estimation of pain reduction in every arm of the trial with linear 1-10 pain scale or for children 4 - 6 years old with analogic MacGrath type scale
Time Frame: 6 hours (or until the end of procedures)
Secondary Outcomes
- comparison between the two groups on effectiveness on pain, measured with linear and analogic scale (see above)(6 hours or until the end of procedures)